Form N-8F/A GLENMEDE PORTFOLIOS

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form N-8F

 

Application for Deregistration of Certain Registered Investment Companies.

 

I.       General Identifying Information

 

1.       Reason fund is applying to deregister (check only one; for descriptions, see Instruction 1 above):

 

☐

Merger

 

✓

Liquidation

 

☐

Abandonment of Registration

(Note: Abandonments of Registration answer only questions 1 through 15, 24 and 25 of this form and complete verification at the end of the form.)

 

☐

Election of status as a Business Development Company

(Note: Business Development Companies answer only questions 1 through 10 of this form and complete verification at the end of the form.)

 

2.       Name of fund: The Glenmede Portfolios

 

3.       Securities and Exchange Commission File No.: 811-06578

 

4.       Is this an initial Form N-8F or an amendment to a previously filed Form N-8F?

 

☐     Initial Application            ☑      Amendment

 

5.       Address of Principal Executive Office (include No. & Street, City, State, Zip Code):

 

c/o State Street Bank and Trust Company

One Congress Street, Suite 1

Boston, Massachusetts 02114

 

 

6.

Name, address, and telephone number of individual the Commission staff should contact with any questions regarding this form:

 

Cheri R. Williams

Faegre Drinker Biddle & Reath LLP

One Logan Square, Suite 2000

Philadelphia, Pennsylvania 19103

(215) 988-2571

Email: [email protected]

 

7.

Name, address and telephone number of individual or entity responsible for maintenance and preservation of fund records in accordance with rules 31a-1 and 31a-2 under the Act [17 CFR 270.31a-1, .31a-2]:

 

Glenmede Investment Management LP

One Liberty Place

1650 Market Street, Suite 4000

Philadelphia, Pennsylvania 19103

(215) 419-6021

(records relating to its functions as investment advisor)

 

State Street Bank and Trust Company

One Congress Street, Suite 1

Boston, MA 02114

(617) 662-3969

(records relating to its functions as custodian, administrator, transfer agent, dividend disbursing agent and securities lending agent)

 

Quasar Distributors, LLC

3 Canal Plaza

Suite 100

Portland, ME 04101

484-320-6232

(records relating to its functions as distributor)

 

Faegre Drinker Biddle & Reath LLP

One Logan Square

Suite 2000

Philadelphia, Pennsylvania 19103-6996

(215) 988-2700

(Registrant’s minute books)

 

NOTE: Once deregistered, a fund is still required to maintain and preserve the records described in rules 31a-1 and 31a-2 for the periods specified in those rules.

 

8.       Classification of fund (check only one):

 

☑       Management company;

☐    Unit investment trust; or

☐    Face-amount certificate company.

 

9.        Subclassification if the fund is a management company (check only one):

 

☑       Open-end              ☐      Closed-end

 

10.      State law under which the fund was organized or formed (e.g., Delaware, Massachusetts):

 

Massachusetts

 

11.

Provide the name and address of each investment adviser of the fund (including sub-advisers) during the last five years, even if the fund’s contracts with those advisers have been terminated:

 

Glenmede Investment Management LP

One Liberty Place

1650 Market Street, Suite 4000

Philadelphia, Pennsylvania 19103

 

12.

Provide the name and address of each principal underwriter of the fund during the last five years, even if the fund’s contracts with those underwriters have been terminated:

 

Quasar Distributors, LLC

3 Canal Plaza

Suite 100

Portland, ME 04101

 

13.      If the fund is a unit investment trust (“UIT”) provide:

 

(a)

Depositor’s name(s) and address(es):

 

(b)   Trustee’s name(s) and address(es):

 

14.

Is there a UIT registered under the Act that served as a vehicle for investment in the fund (e.g., an insurance company separate account)?

 

☐     Yes                 ☑     No

 

If Yes, for each UIT state:

 

Name(s):

 

File No.: 811-

 

Business Address:

 

15.

(a)

Did the fund obtain approval from the board of directors concerning the decision to engage in a Merger, Liquidation or Abandonment of Registration?

 

☑       Yes                ☐       No

 

If Yes, state the date on which the board vote took place:

 

December 4, 2025

 

If No, explain:

 

(b)

Did the fund obtain approval from the shareholders concerning the decision to engage in a Merger, Liquidation or Abandonment of Registration?

 

☐       Yes                ☑        No

 

If Yes, state the date on which the shareholder vote took place:

 

If No, explain: The organizational documents of The Glenmede Portfolios (the “Fund”) do not require shareholder approval to liquidate and terminate the Fund, except for the Muni Intermediate Portfolio (the “Muni Portfolio”), which requires shareholder approval unless no shares are outstanding. On June 28, 2024, prior to the Liquidation, all outstanding shares of the Muni Portfolio—the Fund’s only remaining series—were redeemed by shareholders, and the Muni Portfolio was immediately closed to new investments.

 

II.        Distributions to Shareholders

 

16.

Has the fund distributed any assets to its shareholders in connection with the Merger or Liquidation?

 

☐        Yes              ☑         No

 

Since all shareholders redeemed out of the Fund prior to the Liquidation, no distribution of assets was necessary.

 

(a)

If Yes, list the date(s) on which the fund made those distributions: N/A

 

(b)

Were the distributions made on the basis of net assets? N/A

 

☐          Yes            ☐          No

 

(c)

Were the distributions made pro rata based on share ownership? N/A

 

☐          Yes             ☐          No

 

(d)

If No to (b) or (c) above, describe the method of distributions to shareholders. For Mergers, provide the exchange ratio(s) used and explain how it was calculated: N/A

(e)

Liquidations only: N/A

 

Were any distributions to shareholders made in kind?

 

☐        Yes            ☐         No

 

If Yes, indicate the percentage of fund shares owned by affiliates, or any other affiliation of shareholders:

 

17.	Closed-end funds only:

 

Has the fund issued senior securities?

 

☐           Yes          ☐        No

 

If Yes, describe the method of calculating payments to senior securityholders and distributions to other shareholders:

 

18.	Has the fund distributed all of its assets to the fund’s shareholders?

 

☐         Yes           ☑            No (Please refer the information provided in Question 16 above describing why no distribution of assets was required.)

 

If No,

 

(a)

How many shareholders does the fund have as of the date this form is filed? N/A

 

(b)

Describe the relationship of each remaining shareholder to the fund: N/A

 

19.

Are there any shareholders who have not yet received distributions in complete liquidation of their interests?

 

☐         Yes          ☑           No

 

If Yes, describe briefly the plans (if any) for distributing to, or preserving the interests of, those shareholders:

 

III.      Assets and Liabilities

 

20.     Does the fund have any assets as of the date this form is filed?

(See question 18 above)

 

☐      Yes             ☑             No

 

If Yes,

(a)

Describe the type and amount of each asset retained by the fund as of the date this form is filed:

 

(b)

Why has the fund retained the remaining assets?

 

(c)

Will the remaining assets be invested in securities?

 

☐       Yes          ☐          No

 

21.

Does the fund have any outstanding debts (other than face-amount certificates if the fund is a face-amount certificate company) or any other liabilities?

 

☐        Yes         ☑         No

 

If Yes,

 

(a)

Describe the type and amount of each debt or other liability:

 

(b)

How does the fund intend to pay these outstanding debts or other liabilities?

 

IV.       Information About Event(s) Leading to Request For Deregistration

 

22.

(a)

List the expenses incurred in connection with the Merger or Liquidation:

 

(i)

Legal expenses: $1,330.50

(ii)

Accounting expenses: $0

(iii)

Other expenses (list and identify separately):

 

Trustee Payments: $24,071.15

State Filings: $496

 

(iv)

Total expenses (sum of lines (i)-(iii) above): $25,897.65

 

(b)

How were those expenses allocated? Glenmede Investment Management LP paid all of the expenses described above.

 

 

(c)

Who paid those expenses? Please see (b) above.

 

(d)

How did the fund pay for unamortized expenses (if any)? N/A

 

23.

Has the Fund previously filed an application for an order of the Commission regarding the Merger or Liquidation?

 

☐       Yes             ☑         No

If Yes, cite the release numbers of the Commission’s notice and order or, if no notice or order has been issued, the file number and date the application was filed:

 

V.        Conclusion of Fund Business

 

24.      Is the fund a party to any litigation or administrative proceeding?

 

☐       Yes             ☑         No

 

If Yes, describe the nature of any litigation or proceeding and the position taken by the fund in that litigation:

 

25.

Is the fund now engaged, or intending to engage, in any business activities other than those necessary for winding up its affairs?

 

☐          Yes             ☑         No

 

If Yes, describe the nature and extent of those activities:

 

VI.      Mergers Only

 

26.

(a)

State the name of the fund surviving the Merger:

 

(b)

State the file number of the fund surviving the Merger:

 

(d)

If the merger or reorganization agreement has been filed with the Commission, state the file number and date the agreement was filed:

 

(d)

If the merger or reorganization agreement has not been filed with the Commission, attach a copy of the agreement as an exhibit to this form.

VERIFICATION

 

The undersigned states that (i) she has executed this Form N-8F application for an order under section 8(f) of the Investment Company Act of 1940 on behalf of The Glenmede Portfolios, (ii) she is the President of The Glenmede Portfolios, and (iii) all actions by shareholders, directors, and any other body necessary to authorize the undersigned to execute and file this Form N-8F application has been taken. The undersigned also states that the facts set forth in this Form N-8F application are true to the best of his or her knowledge, information, and belief.

 

 

	Signature	/s/ Elizabeth A. Eldridge
	By	Elizabeth A. Eldridge
	Title	President
	Date	March 31, 2026

 

 

ATTACHMENTS / EXHIBITS

SECRETARYS CERTIFICATION

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Celyad Oncology Announces €500,000 Private Placement
• Clarivate Selected by Abes to Modernize French National Academic Library System
• T-REX Launches T-REX 2X Long SKHY Daily Target ETF (NYSE Arca: HYNX)